Efficacy and safety of live combined Bacillus subtilis and Enterococcus faecium in patients with Helicobacter pylori infection: A meta-analysis of randomized controlled trials
Chenghai Yang, Bingyun Lu, Cangui Zhang, Anjiang Wang, Ye Chen · 2026
Read Efficacy and safety of live combined Bacillus subtilis and Enterococcus faecium in patients with Helicobacter pylori infection: A meta-analysis of randomized controlled trials by Chenghai Yang, Bingyun Lu, Cangui Zhang, Anjiang Wang, Ye Chen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13586577.txt.
Description
Adding a probiotic pair to standard stomach germ therapy may raise cure rates and calm side effects, and a meta-analysis pooled the randomized trials. Chenghai Yang and co-authors carried out that pooling in this 2026 paper. Six databases were searched to February twenty twenty-five for trials that added the live bacteria pair or not.
The pair pairs a spore-forming Bacillus with a gut Enterococcus strain sold as one product. Outcomes covered eradication of the stomach germ and adverse events. The germ drives ulcers and stomach cancer, and rising antibiotic resistance is eroding standard therapy. A cheap, safe add-on that lifts cure rates would matter most where resistance is highest. The pooled verdict helps doctors judge the add-on beyond single small trials.
Catalog record
| CREATOR | Chenghai Yang, Bingyun Lu, Cangui Zhang, Anjiang Wang, Ye Chen |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |